Calcium blocker therapy before myocardial infarction increases post-infarction short- and long-term mortality: Data from the inject trial;Leczenie blokerami kanału wapniowego przed zawałem serca zwiȩksza ryzyko zgonu: Obserwacja wczesna i odległa. Wyniki na podstawie badania inject

Kardiologia Polska

Volumn 57, Issue 12, 2002, Pages 512-519

  Stepińska, Janina ^a   Sadowski, Zygmunt ^a   Szajewski, Tomasz ^a   Banaszewski, Marek ^a   Wojciechowski, Dariusz ^b   Kraska, Tadeusz ^c   Nartowicz, Edmund ^c   Kuch, Jerzy ^d  

^a INSTITUTE OF CARDIOLOGY   (Poland)

^b Wolski Hospital   (Poland)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

^d NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Calcium blockers; Mortality; Myocardial infarction

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; RETEPLASE; STREPTOKINASE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGINA PECTORIS; ARTICLE; ASYSTOLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FIBRINOLYTIC THERAPY; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART SUPRAVENTRICULAR ARRHYTHMIA; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0036906373     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Buring J.E., Glynn R.J., Hennekens Ch.H.: Calcium channel blockers and myocardial infarction. JAMA 1995, 274 (8), 654-655.
2. Opie L.H., Messerli F.H.: Nifedipine and mortality. Grave defects in the dossier. Circulation 1995, 92, 1068-1073.
3. Yusuf S.: Verapamil following uncomplicated myocardial infarction: Promissing, but not proven. Am. J. Cardiol. 1996, 77, 421.
4. Psaty B.M., Heckbert S.R., Koepsell T.D. et al.: The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995, 274, 620-625.
5. INJECT: Randomised, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction: Trial to investigate equivalence. Lancet 1995, 346, 329-336.
6. Villari B., Ambrosio G., Golino P. et al.: The effects of calcium channel antagonist treatment and oxygen radical scavenging on infarct size and the no-reflow phenomenon in reperfused hearts. Am. Heart J. 1993, 125, 11.
7. Held P.H., Yusuf S., Furberg C.D.: Calcium channel blockers in acute myocardial infarction and unstable angina: An overview. Br. Med. J. 1989, 299, 1187-1192.
8. Reeder G.S.: Concise review for primary-care physicians. Adjunctive therapy in the management of patients with acute myocardial infarction. Mayo Clin. Proc. 1995, 70, 464-468.
9. Sellier P.: Angina pectoris in patients with a history of myocardial infarction. Eur. Heart J. 1996, 17 (suppl. G), 25-29.
10. Kostis J.B., Lacy C.R., Cosgrove N.M. et al.: Association of calcium channel blocker use with increased rate of acute myocardial infarction in patients with left ventricular dysfunction. Am. Heart J. 1997, 133, 550-557.
11. Boden W.E., Scheldewaert R., Walters E.G. et al.: Design of a placebo-controlled clinical trial of long-acting diltiazem and aspirin versus aspirin alone in patients receiving thrombolysis with a first acute myocardial infarction. Am. J. Cardiol. 1995, 75, 1120-1123.
12. Ishikawa K., Nakai S., Takenaka T. et al.: Short-acting nifedipine and diltiazem do not reduce the incidence of cardiac events in patients with healed myocardial infarction. Circulation 1997, 95, 2368-2373.
13. Nicolau J.C., Ramires J.A.F., Maggioni A.P. et al.: Diltiazem improves left ventricular systolic function following acute myocardial infarction treated with streptokinase. Am. J. Cardiol. 1996, 78, 1049.
14. Jespersen C.M.: Anti-ischaemic intervention with vempamil in patients recovering from acute myocardial infarction. Eur. Heart J. 1995, 16 (suppl. H), 13-17.
15. Jespersen C.M., Hansen J.F., Mortensen L.S. et al.: The prognostic significance of post-infarction angina pectoris and the effect of verapamil on the incidence of angina pectoris and prognosis. Eur. Heart J. 1994, 15, 270-276.
16. Pepine C.J.: Use of calcium antagonists in postmyocardial infarction patients. JACC 1997, 31 (1), 118.